{"id":"NCT01634256","sponsor":"Chonbuk National University Hospital","briefTitle":"A Human Trial to Evaluate the Efficacy and Safety of Fermented Turmeric in Subjects Showing Mild Hepatic Injury","officialTitle":null,"status":"COMPLETED","phase":"PHASE2","dates":{"start":"2011-02","primaryCompletion":"2011-10","completion":"2012-01","firstPosted":"2012-07-06","resultsPosted":"2012-10-04","lastUpdate":"2012-10-04"},"enrollment":60,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"PREVENTION"},"conditions":["Mild Hepatic Injury"],"interventions":[{"type":"DIETARY_SUPPLEMENT","name":"Placebo","otherNames":[]},{"type":"DIETARY_SUPPLEMENT","name":"Fermented turmeric","otherNames":[]}],"arms":[{"label":"Fermented turmeric","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The investigators performed a double-blind parallel study in a group of showing mild hepatic injury subjects who were given Fermented turmeric over a period of 12 weeks. The investigators measured liver function parameters , including ALT(Alanine Transaminase), AST(Aspartate Transaminase), ALP(Alkaline Phosphatase), Î³-GT(Gamma-Glutamyl Transferase), and serum bilirubin, and monitored their blood pressure.","primaryOutcome":{"measure":"Changes in ALT(Alanine Transaminase)","timeFrame":"12 weeks","effectByArm":[{"arm":"Fermented Turmeric","deltaMin":61.08,"sd":25.1},{"arm":"Placebo","deltaMin":55.68,"sd":15.09}],"pValues":[]},"eligibility":{"minAge":"19 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":3,"exclusionCount":11},"locations":{"siteCount":1,"countries":["South Korea"]},"refs":{"pmids":["23497020"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":30},"commonTop":[]}}